Skip to main content

Article Filters

Clear Filters
Finish

Prometic Bioseparations to become Astrea Bioseparations

Published date: 13 January 2020

Back to Article Listing

Ballasalla, Isle of Man, British Isles and Cambridge, UK – January 13th, 2020 – Prometic Bioseparations Ltd announced today that it is changing its name to Astrea Bioseparations Ltd.

“This name change follows our divestment from Liminal Biosciences and demonstrates a re-focus on providing products and services that support the highest quality and purity for biotherapeutics. We chose ‘Astrea – the Goddess of Purity’ to reflect the capability of our ligand discovery platform by providing world leading affinity chromatography adsorbents for both recombinant proteins and Gene Therapy products.” said Dr. Steve Burton, CEO of Astrea.

“Astrea Bioseparations is the only bioseparations company that can provide ligand discovery, adsorbent development and scale up, large scale adsorbent manufacture (up to 1000L batches) and GMP pre-packed columns,” Dr. Burton added.

Along with the new name a new website has been launches, to find out more please visit www.astreabioseparations.com.

About Astrea Bioseparations Ltd.

Astrea Bioseparations Ltd. (formerly Prometic Bioseparations Ltd) (https://www.astreabioseparations.com) is a bioseparations company specializing in the research, development, manufacture and marketing of bioseparation products including chromatography adsorbents and pre-packed chromatography columns. A wholly owned subsidiary of Gamma Biosciences, a KKR & Co. company, Astrea Bioseparations has R&D laboratories located at Cambridge, UK and manufacturing facilities located at the Isle of Man, British Isles and Joliette, Quebec, Canada.

FOR FURTHER INFORMATION PLEASE CONTACT:

Hannah Ingram
Head of Marketing
h.ingram@astrea-bio.com
+44 (0)1223 736 983

Your basket

Your basket is empty. Continue shopping to add products to your basket.

Search our catalogue

Call Centre

Request Quote

Please enter the quantity of products you want a quote for

Please enter the date you need these products byPlease enter a date in the format DD/MM/YYYY

View Content

Please complete the form below to receive the requested content from Astrea Bioseparations. We will use the data you provide to send you relevant updates, special offers, and product-related information. See our Privacy Notice for details on how we use personal data.

If you have an account please log in to gain access to content. You can apply for an account here

Please enter a First Name

Please enter a valid First Name, the maximum length is 50 characters.

Please enter a Last Name

Please enter a valid Last Name, the maximum length is 50 characters.

Please enter a Company Name

Please enter a valid Company, the maximum length is 100 characters

Please enter a valid Email AddressPlease enter a valid Email AddressThe Email Address entered is already registered, please sign in with the Email Address or enter a different one

Please select a valid Telephone Number, the maximum length is 30 characters

Please enter a valid Telephone Number consisting only of the following characters and spaces ( ) + 0 1 2 3 4 5 6 7 8 9

Please select a State / Province / Territory

Please select a valid State / Province / Territory, the maximum length is 150 characters

Please select a Country

Data entered into form will be stored in your session (not in a cookie) to avoid having to re-enter in future form submissions.

Prometic Bioseparations to become Astrea Bioseparations

Published date: 13 January 2020

Back to Article Listing

Ballasalla, Isle of Man, British Isles and Cambridge, UK – January 13th, 2020 – Prometic Bioseparations Ltd announced today that it is changing its name to Astrea Bioseparations Ltd.

“This name change follows our divestment from Liminal Biosciences and demonstrates a re-focus on providing products and services that support the highest quality and purity for biotherapeutics. We chose ‘Astrea – the Goddess of Purity’ to reflect the capability of our ligand discovery platform by providing world leading affinity chromatography adsorbents for both recombinant proteins and Gene Therapy products.” said Dr. Steve Burton, CEO of Astrea.

“Astrea Bioseparations is the only bioseparations company that can provide ligand discovery, adsorbent development and scale up, large scale adsorbent manufacture (up to 1000L batches) and GMP pre-packed columns,” Dr. Burton added.

Along with the new name a new website has been launches, to find out more please visit www.astreabioseparations.com.

About Astrea Bioseparations Ltd.

Astrea Bioseparations Ltd. (formerly Prometic Bioseparations Ltd) (https://www.astreabioseparations.com) is a bioseparations company specializing in the research, development, manufacture and marketing of bioseparation products including chromatography adsorbents and pre-packed chromatography columns. A wholly owned subsidiary of Gamma Biosciences, a KKR & Co. company, Astrea Bioseparations has R&D laboratories located at Cambridge, UK and manufacturing facilities located at the Isle of Man, British Isles and Joliette, Quebec, Canada.

FOR FURTHER INFORMATION PLEASE CONTACT:

Hannah Ingram
Head of Marketing
h.ingram@astrea-bio.com
+44 (0)1223 736 983

Call Centre Product Compare